A carregar...
Dasatinib‐induced pulmonary arterial hypertension
Drug‐induced (group 1) pulmonary hypertension (PH) is an important subgroup of PH involving dasatinib as a likely related agent, which is a second‐generation tyrosine kinase inhibitor (TKI) used in the treatment of chronic myeloid leukaemia (CML). The mechanism of dasatinib‐induced pulmonary arteria...
Na minha lista:
| Publicado no: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5903230/ https://ncbi.nlm.nih.gov/pubmed/29334406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13508 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|